Search results
New AI-Based Blood Test Can Predict Parkinson’s Disease Seven Years Before Symptoms
SciTechDaily· 11 hours agoA new AI-enhanced blood test can predict Parkinson’s disease up to seven years in advance by analyzing specific biomarkers, potentially enabling earlier and more effective ...
Living Drugs that Fight Cancer | Newswise
Newswise· 21 hours agoAlthough the process collects patients’ own white blood cells, they must still undergo a mild chemotherapy to weaken their immune systems — known as...
US FDA approves Roche's drug for a chronic blood disorder (June 21)
Reuters via AOL· 3 days agoThe U.S. Food and Drug Administration on Thursday approved Roche's drug for a chronic blood disorder...
US FDA approves Roche's drug for a chronic blood disorder
Reuters· 3 days ago, opens new tab drug for a chronic blood disorder, the Swiss drugmaker said. The drug crovalimab,...
Preeclampsia Can Be Fatal for Pregnant People and Babies. New Blood Tests Aim to Show Who's at Risk
US News & World Report· 13 hours agoNew blood tests may help doctors predict and manage this dangerous condition. “When something bad happens in pregnancy, you want to catch it early so you can avoid adverse ...
Volkswagen donates 2024 Jetta S to be raffled among blood donors
Glendale Star· 4 days agoDonors who give blood through Sept. 6 with Vitalant will be automatically entered to win a 2024 VW...
New blood test may predict Parkinson's years before symptoms
United Press International via Yahoo News· 6 days agoThey then tested the program's ability to predict whether a person would go on to develop...
US FDA approves Roche’s drug for a chronic blood disorder
WSAU Wausau· 3 days ago(Reuters) - The U.S. Food and Drug Administration on Thursday approved Roche's drug for a chronic ...
US FDA approves Roche's drug for a chronic blood disorder
AOL· 3 days agoThe drug crovalimab, branded as PiaSky, is a monthly under-the-skin or intravenous treatment for paroxysmal nocturnal hemoglobinuria (PNH). PNH is a disorder in which red blood cells break apart prematurely.
Novo fills in positive picture for preventive hemophilia drug
BioPharma Dive via Yahoo Finance· 14 hours agoPhase 3 trial results should support an approval application for the drug, which analysts view as a...
